Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries
- PMID: 29528996
- PMCID: PMC6129444
- DOI: 10.1097/OLQ.0000000000000832
Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries
Abstract
Background: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) infections during pregnancy are linked with adverse birth outcomes. However, few countries have prenatal CT, NG, or TV screening programs. In this study, we aimed to evaluate the acceptability and feasibility of CT, NG, and TV screening and treatment among pregnant women across 6 low- to middle-income countries.
Methods: A total of 1817 pregnant women were screened for CT, NG, and TV in Botswana, the Democratic Republic of Congo, Haiti, South Africa, and Vietnam. An additional 640 pregnant women were screened for CT in Peru. Screening occurred between December 2012 and October 2017. Acceptability of screening was evaluated at each site as the proportion of eligible women who agreed to participate in screening. Feasibility of treatment was calculated as the proportion of women who tested positive that received treatment.
Results: Acceptability of screening and feasibility of treatment was high across all 6 sites. Acceptability of screening ranged from 85% to 99%, and feasibility of treatment ranged from 91% to 100%.
Discussion: The high acceptability and feasibility of screening and treatment of CT, NG, and TV among pregnant women supports further research to evaluate the cost-effectiveness of prenatal CT, NG, and TV screening programs.
Conflict of interest statement
Similar articles
-
Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis screening and treatment of pregnant women in Port-au-Prince, Haiti.Int J STD AIDS. 2017 Oct;28(11):1130-1134. doi: 10.1177/0956462416689755. Epub 2017 Jan 29. Int J STD AIDS. 2017. PMID: 28134005 Free PMC article.
-
Prevalence and treatment outcomes of routine Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing during antenatal care, Gaborone, Botswana.Sex Transm Infect. 2018 May;94(3):230-235. doi: 10.1136/sextrans-2017-053134. Epub 2017 Nov 2. Sex Transm Infect. 2018. PMID: 29097418 Free PMC article.
-
Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.Reprod Health. 2021 Jun 26;18(1):132. doi: 10.1186/s12978-021-01179-8. Reprod Health. 2021. PMID: 34174905 Free PMC article.
-
Issues in the management of sexually transmitted diseases in Papua New Guinea.P N G Med J. 1996 Sep;39(3):252-60. P N G Med J. 1996. PMID: 9795576 Review.
-
Maternal Prenatal Screening and Serologies.Adv Neonatal Care. 2018 Dec;18(6):431-437. doi: 10.1097/ANC.0000000000000568. Adv Neonatal Care. 2018. PMID: 30499824 Review.
Cited by
-
Prevalence assessment of sexually transmitted infections among pregnant women visiting an antenatal care center of Nepal: Pilot of the World Health Organization's standard protocol for conducting STI prevalence surveys among pregnant women.PLoS One. 2021 Apr 23;16(4):e0250361. doi: 10.1371/journal.pone.0250361. eCollection 2021. PLoS One. 2021. PMID: 33891652 Free PMC article.
-
Associated factors of willingness to undergo routine chlamydia trachomatis screening among hospital-based patients in Shenzhen, China: a cross-sectional study.BMC Public Health. 2020 Nov 16;20(1):1720. doi: 10.1186/s12889-020-09828-6. BMC Public Health. 2020. PMID: 33198730 Free PMC article.
-
Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trial.Trials. 2022 May 24;23(1):441. doi: 10.1186/s13063-022-06400-y. Trials. 2022. PMID: 35610666 Free PMC article.
-
Preconception health risks among women of reproductive age in Sub-Saharan Africa: a systematic review of implications for preconception care.J Health Popul Nutr. 2025 May 21;44(1):164. doi: 10.1186/s41043-025-00888-1. J Health Popul Nutr. 2025. PMID: 40399959 Free PMC article. Review.
-
Persistent Chlamydia trachomatis, Neisseria gonorrhoeae or Trichomonas vaginalis positivity after treatment among human immunodeficiency virus-infected pregnant women, South Africa.Int J STD AIDS. 2020 Mar;31(4):294-302. doi: 10.1177/0956462419898612. Epub 2020 Feb 23. Int J STD AIDS. 2020. PMID: 32089090 Free PMC article.
References
-
- World Health Organization. Global health sector strategy on sexually transmitted infections, 2016–2021. 2016 - PubMed
-
- Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sexually Transmitted Diseases. 1997;24(6):353–60. - PubMed
-
- de Attayde MJPM, Florêncio GLD, Gabiatti JRE, et al. Perinatal morbidity and mortality associated with chlamydial infection: a meta-analysis study. Braz J Infect Dis. 2011;15(6):533–9. - PubMed
-
- Gencay M, Koskiniemi MA, Pirkko S, et al. Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. Apmis. 2000;108(9):584–588. - PubMed
-
- Schachter J, Grossman M, Sweet R, et al. Prospective study of perinatal transmission of Chlamydia trachomatis. Jama. 1986;255(24):3374–3377. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical